Registrations for this event have gone well. We are now nearly sold out. To network with the World’s leading patient adherence experts, REGISTER NOW without delay.

"Industry awareness of the importance of patient compliance has grown substantially during the last five years. eyeforpharma's 2007 US event is without doubt the one that will provide you with both an overview of state-of-the-art approaches and pragmatic industry solutions"
Len Starnes, Head of Global E-Business, Bayer Schering

Overview

It is said in every challenge lies a hidden opportunity for those wise enough to recognize it. Perhaps nowhere is this truer than when it comes to patient adherence and persistence.

The challenge is great. Experts estimate that patient non-adherence costs the pharmaceutical industry in excess of $30 billion a year – not to mention, the chance at a fuller, healthier life for countless patients.

The opportunity is greater. Clinical researchers estimate that for most prescribed drugs, patient compliance rates are 50-60%, but with some disease states, compliance drops as low as 10-20%. So, even modest improvements in adherence and persistence can have significant, positive impacts on not only revenues for drug makers, but expenses for third party payers and outcomes for patients.

Improving compliance is a win-win for everyone in the patient care equation.

Is your company prepared to meet the challenge and discover the opportunity of improved patient adherence and persistence?

A few confirmed speakers include:

Cathy Mecker, Global Marketing Director for Patient Adherence, Eli Lilly and Company
David Baker, Vice President & General Manager, ADHD Business Unit, Shire
Steve Basiago, Vice President, Trade Relations, Walgreens Health Services
Melody Boyd, Head of Clinical R & D, Intercytex
Sandipa Dublish, Director, Oncology Market Research, Bristol Myers Squibb
Murat V. Kalayoglu, MD, PhD, Harvard University
Dr. Andrea LaFountain, Senior Manager, Consumer Insights, AstraZeneca
Craig Lipset, Director, Health Technologies, Pfizer, Inc.
Pablo Przygoda, Product Manager, Patient Initiatives, Actelion Pharmaceuticals US, Inc.
Marc Rovner, Managing Director, SmartAnalyst, formerly, VP, Global New Markets, Johnson & Johnson
Nayan R. Shah, Assistant Professor of Medicine , Georgetown University Medical Center, Mid-Atlantic Medical Research Centers Inc.
Michael S. Singer, MD, PhD, Harvard University
Dr Michael Sokol, Director, Disease Management, GlaxoSmithKline
Rachel Bevis, APC Director of Marketing Strategy, AstraZeneca

…30 Speakers confirmed, with more to come!

Download the brochure

The topics below will be covered at our unique conference:

Multi-stakeholder Collaboration : How closer ties with payers, disease management providers, chain drugstores and other key stakeholders will help you overcome the costly problem of non-compliance in your patient groups

Latest Industry Case Studies demonstrate how to mix tools and marketing channels to build patient commitment

State-of-the-Art Technology What can realistically be used today to make real bottom-line impact?

Developing patient relations : Learn how to develop a fully integrated program, and leverage the value from different patient segments

Strengthen the patient-physician relationship : discover how small changes in physician behavior will result in improved levels of adherence and persistence

Reduce barriers to adhere from the start : Learn how to increase profitability by designing in patient adherence at the R&D stage

Regulations are for your benefit : Make the case for higher levels of patient communications and develop a collaborative approach with regulators

Measure ROI: best practice guidelines for proving effectiveness of adherence programs

Please send your ideas, suggestions, proposals to Takuya Shimada on tshimada@eyeforpharma.com (or +1 800 814 3459 x212).